Blood and gel combo may strengthen dental implant bone growth
NCT ID NCT07792720
First seen Aug 28, 2026 · Last updated Sep 03, 2026 · Updated 2 times
Summary
This trial tests whether applying a gel made from a patient's own blood, called advanced platelet-rich fibrin (A-PRF), along with hyaluronic acid, can improve bone formation around dental implants. Adults aged 18 to 65 who need a delayed implant in the lower jaw will either receive the standard implant procedure or the implant plus the A-PRF and hyaluronic acid combination. Researchers will measure bone density and volume using 3D imaging, as well as implant stability, pain, and implant survival over six months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Advanced platelet-rich fibrin (A-PRF) combined with hyaluronic acid, applied at the dental implant site
- What this could lead to
- If it works, this could point toward a way to improve bone healing around dental implants, potentially reducing implant failure and improving long-term outcomes.
- What could go wrong
- This is a small, early-stage trial with only 30 participants, so results may not apply broadly. The added biomaterials could also carry risks like infection or inflammation, and the benefit over standard care is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Adults aged 18-65 years. Patients requiring delayed dental implant placement in a posterior mandibular edentulous site Sufficient residual alveolar bone height and width to permit conventional implant placement without the need for simultaneous guided bone regeneration (GBR), ridge augmentation, or other bone-grafting procedures. Good general health or a medically controlled and stable systemic condition compatible with elective implant surgery and not expected to materially compromise wound or bone healing. Non-smokers with no current use of tobacco products. Acceptable oral hygiene and a periodontal condition compatible with implant surgery following any required professional treatment and reassessment. Ability and willingness to undergo the required clinical and radiographic assessments, including CBCT examinations at baseline and at the 6-month follow-up. Ability and willingness to attend the scheduled follow-up visits and comply with the study procedures. Provision of written informed consent before study participation. Exclusion Criteria: \- Any uncontrolled systemic disease or medical condition that conensions for conventional implant placement without augmentation. Requirement for immediate implant placement, simultaneous guided bone regeneration, ridge augmentation, or any other adjunctive bone-grafting procedure. Inability or unwillingness to complete the required 6-month clinical and radiographic follow-up.traindicates elective implant surgery or may substantially impair wound or bone healing, including uncontrolled diabetes mellitus. Immunocompromised status or current systemic immunosuppressive therapy. Current or previous use of oral or parenteral bisphosphonates or other antiresorptive medications associated with a risk of medication-related osteonecrosis of the jaw. Pregnancy at the time of screening or enrollment. Unresolved active periodontal disease or active local infection involving the intended implant site, including suppuration. Inadequate oral hygiene that persists after professional oral-hygiene instruction, necessary periodontal treatment, and reassessment. Insufficient residual alveolar bone dim
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dental implant placement are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Beauty Smile Dental Center
RECRUITINGSanaa, Sana'a, Yemen
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new dental implant design keep jawbone and gums healthier?
- Can All-Ceramic bridges survive the forces of chewing?
- Can a Glued-On zirconia bridge replace a missing tooth without implants?
- Can dental implants be placed right after sinus grafting?
- Can a single drill match full computer guidance for dental implants?
- Plastic vs. metal: which denture material wins for comfort and cost?